Activity value 75china Buyer&Supplier,Last transaction date:
2026-06-30
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for jewim pharmacueutical shandong co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 48 transactions, with a transaction quantity of 135581.12 and a transaction weight of 151751.22.
Suppliers
jewim pharmacueutical shandong co.ltd.
Buyers
b c n medical s.a.
POLs
——
PODs
buenaventura
Supply area
China
Purchas area
Colombia
Weight
1350kg
Amount
33444.96
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
DO 2026001608 CODIGO RESOLUCION USUARIO TRAMITE SIMPLIFICADO (UTS) U00806 DECLARACION(3 4) PRODUCTO MEDICAMENTO NOMBRE COMERCIAL ECLOSYNT PRINCIPIO ACTIVO BECLOMETASONA DIPROPIONATO CONCENTRACION CADA 100 G DE PRODUCTO CONTIENE BECLOMETASONA DIPROPIONATO .070% (W W) INDICACIONES TERAPEUTICAS PROFILAXIS EN EL TRATAMIENTO DE ASMA BRONQUIAL. FORMA FARMACEUTICA AR AEROSOLES TIPO DE EMPAQUE PRESENTACION COMERCIAL MUESTRA MEDICA CAJA POR UN INHALADOR DE ALUMINIO POR 200 DOSIS E INSERTO (50MCG DOSIS) CON VALVULA E INYECTOR USO HUMANO MARCA ECLOSYNT FAES FARMA RSI INVIMA 2020M0009084 R1. EXPEDIENTE 19992494 LOTE 2620554 FECHA DE FABRICACION 01 2026 FECHA DE VENCIMIENTO 12 2028. PAIS DE ORIGEN CHINA 215 CANT (30000) U
Expand
Trade date
2026/05/28
B/L No.
92035001649261
Suppliers
jewim pharmacueutical shandong co.ltd.
Buyers
b c n medical s.a.
POLs
——
PODs
buenaventura
Supply area
China
Purchas area
Colombia
Weight
2713.5kg
Amount
86122.2
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
BRONCODILATADOR. INDICADO EN EL TRATAMIENTO DE MANTENIMIENTO DE PACIENTES CON ENFERMEDAD PULMONAR OBSTRUCTIVA CRONICA INCLUIDA BRONQUITIS CRONICA Y ENFISEMA. TERAPIA COMPLEMENTARIA EN LOS CASOS DE EXACERBACIONES SEVERAS O MODERADAS DE ASMA QUE NO RESPONDAN ADECUADAMENTE AL USO DE AGONISTAS 2. FORMA FARMACEUTICA AR AEROSOLES TIPO DE EMPAQUE CAJA PLOR UN FRASCO POR UN INHALADOR DE ALUMINIO POR 200 DOSIS CON VASTAGODE VALVULA DE ACERO INOXIDABLE USO HUMANO MARCA IPRASYNT FAES FARMA RSI INVIMA 2019M0008642 R1. EXPEDIENTE 19992496 LOTE 2620433 FECHA DE FABRICACION 01 2026 FECHA DE VENCIMIENTO 12 2028 2620741 FECHA DE FABRICACION 02 2026 FECHA DE
Expand
Trade date
2026/05/28
B/L No.
92035001649252
Suppliers
jewim pharmacueutical shandong co.ltd.
Buyers
b c n medical s.a.
POLs
——
PODs
buenaventura
Supply area
China
Purchas area
Colombia
Weight
1633.5kg
Amount
49685.19
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
PRODUCTO MEDICAMENTO NOMBRE COMERCIAL ECLOSYNT PRINCIPIO ACTIVO BECLOMETASONA DIPROPIONATO (EQUIIVALENTE A 250 MCG DOSIS) CONCENTRACION CADA 100 GRAMOS DE PRODUCTO CONTIENE BECLOMETASONA DIPROPIONATO 0.42000 %(W W) INDICACIONES TERAPEUTICAS USO TERAPEUTICO PROFILAXIS EN EL TRATAMIENTO DE ASMA BRONQUIAL FORMA FARMACEUTICA AR AEROSOLES TIPO DE EMPAQUE CODIGO IUM 1B1044201000100 BECLOMETASONA 250 0000 G AEROSOL INHALATORIA BUCAL (ECLOSYNT) INHALADOR 200 0000DOSIS USO HUMANO MARCA ECLOSYNT FAES FARMA RSI INVIMA2023M0008643 R1. EXPEDIENTE 19992492 LOTE 2620761. FECHA DE FABRICACION 03 2026 FECHA DE VENCIMIENTO
Expand
Trade date
2026/05/28
B/L No.
92035001649238
Suppliers
jewim pharmacueutical shandong co.ltd.
Buyers
b c n medical s.a.
POLs
——
PODs
buenaventura
Supply area
China
Purchas area
Colombia
Weight
598.5kg
Amount
32194.57
Hs code
3004902900
Product tags
equipped with fixed dose drug
Product description
ACTIVO BROMURO DE TIOTROPIO EQUIVALENTE 21 67 MCG EQUIVALENTE A TIOTROPIO BASE CONCENTRACION CADA CAPSULA CONTIENE BROMURO DE TIOTROPIO EQUIVALENTE 21 67 MCG EQUIVALENTE A TIOTROPIO BASE 18 MCG INDICACIONES TERAPEUTICAS BRONCODILATADOR FORMA FARMACEUTICA CD CAPSULA DUR TIPO DE EMPAQUE CAJA PLEGADIZA DE CARTON POR 30 CAPSULAS EN BLISTER DE PVC ALUMINIO+ DISPOSITIVO FLOWHALER PARA ADMINISTRACION + INSERTO DE USO USO HUMANO MARCA TIOSYNT FAES
Expand
Trade date
2026/05/23
B/L No.
244676
Suppliers
jewim pharmacueutical shandong co.ltd.
Buyers
laboratorios america
jewim pharmacueutical shandong co.ltd. is china Buyer&Supplier,
and primarily engages in the import and export business of products such as equipped with fixed dose drug,alb,mat.
According to the 52wmb.com global trade database, as of 2026-06-30, the company has completed 835 international trades,
with its main trading regions covering pakistan,colombia,sri lanka etc.
The core products include HS3004902900,HS30049090,HS30049099000 etc,
often transported via qingdao,port shanghai, port ching tao etc,
and its main trading partners are getz pharma pvt ltd.,b c n medical s.a.,emerchemie nb ceylon ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on jewim pharmacueutical shandong co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.